Literature DB >> 18241124

Serum-free differentiation of murine embryonic stem cells into alveolar type II epithelial cells.

Monica E Winkler1, Christina Mauritz, Stephanie Groos, Andreas Kispert, Sandra Menke, Anika Hoffmann, Ina Gruh, Kristin Schwanke, Axel Haverich, Ulrich Martin.   

Abstract

Alveolar type II (AT2) epithelial cells have important functions including the production of surfactant and regeneration of lost alveolar type I epithelial cells. The ability of in vitro production of AT2 cells would offer new therapeutic options in treating pulmonary injuries and disorders including genetically based surfactant deficiencies. Aiming at the generation of AT2-like cells, the differentiation of murine embryonic stem cells (mESCs) toward mesendodermal progenitors (MEPs) was optimized using a "Brachyury-eGFP-knock in" mESC line. eGFP expression demonstrated generation of up to 65% MEPs at day 4 after formation of embryoid bodies (EBs) under serum-free conditions. Plated EBs were further differentiated into AT2-like cells for a total of 25 days in serum-free media resulting in the expression of endodermal marker genes (FoxA2, Sox17, TTR, TTF-1) and of markers for distal lung epithelium (surfactant proteins (SP-) A, B, C, and D, CCSP, aquaporin 5). Notably, expression of SP-C as the only known AT2 cell specific marker could be detected after serum-induction as well as under serum-free conditions. Cytoplasmic localization of SP-C was demonstrated by confocal microscopy. The presence of AT2-like cells was confirmed by electron microscopy providing evidence for polarized cells with apical microvilli and lamellar body-like structures. Our results demonstrate the differentiation of AT2-like cells from mESCs after serum-induction and under serum-free conditions. The established serum-free differentiation protocol will facilitate the identification of key differentiation factors leading to a more specific and effective generation of AT2-like cells from ESCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241124     DOI: 10.1089/clo.2007.0075

Source DB:  PubMed          Journal:  Cloning Stem Cells        ISSN: 1536-2302


  17 in total

1.  Design and development of tissue engineered lung: Progress and challenges.

Authors:  Joan E Nichols; Jean A Niles; Joaquin Cortiella
Journal:  Organogenesis       Date:  2009-04       Impact factor: 2.500

2.  Embryonic stem cells and repair of lung injury.

Authors:  Daniel J Weiss; Christine Finck
Journal:  Mol Ther       Date:  2010-03       Impact factor: 11.454

3.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  NKX2-1 activation by SMAD2 signaling after definitive endoderm differentiation in human embryonic stem cell.

Authors:  Yong Li; Kristel Eggermont; Veerle Vanslembrouck; Catherine M Verfaillie
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

Review 5.  Stem cells and regenerative medicine in lung biology and diseases.

Authors:  Allison N Lau; Meagan Goodwin; Carla F Kim; Daniel J Weiss
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

6.  Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.

Authors:  Xueyan Zhang; Yuqing Lou; Huimin Wang; Xiaoxuan Zheng; Qianggang Dong; Jiayuan Sun; Baohui Han
Journal:  Med Oncol       Date:  2015-03-03       Impact factor: 3.064

7.  Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells.

Authors:  Tyler A Longmire; Laertis Ikonomou; Finn Hawkins; Constantina Christodoulou; Yuxia Cao; J C Jean; Letty W Kwok; Hongmei Mou; Jayaraj Rajagopal; Steven S Shen; Anne A Dowton; Maria Serra; Daniel J Weiss; Michael D Green; Hans-Willem Snoeck; Maria I Ramirez; Darrell N Kotton
Journal:  Cell Stem Cell       Date:  2012-04-06       Impact factor: 24.633

8.  Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application.

Authors:  Blair Roszell; Mark J Mondrinos; Ariel Seaton; Donald M Simons; Sirma H Koutzaki; Guo-Hua Fong; Peter I Lelkes; Christine M Finck
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

9.  Strategies for whole lung tissue engineering.

Authors:  Elizabeth A Calle; Mahboobe Ghaedi; Sumati Sundaram; Amogh Sivarapatna; Michelle K Tseng; Laura E Niklason
Journal:  IEEE Trans Biomed Eng       Date:  2014-03-28       Impact factor: 4.538

10.  Sox17 promotes cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate progenitor cell behavior in the respiratory epithelium.

Authors:  Alexander W Lange; Angela R Keiser; James M Wells; Aaron M Zorn; Jeffrey A Whitsett
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.